Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
HRS-9813 in Idiopathic Pulmonary Fibrosis: NCT07192939 Clinical Landscape Report 2026
9 min read
HRS-9813 in Idiopathic Pulmonary Fibrosis: NCT07192939 Clinical Landscape Report 2026
18 September 2026
NCT07192939 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Temozolomide in Glioblastoma Multiforme: NCT07195591 Clinical Landscape Report 2026
9 min read
Temozolomide in Glioblastoma Multiforme: NCT07195591 Clinical Landscape Report 2026
18 September 2026
NCT07195591 clinical landscape for Glioblastoma Multiforme: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Nintedanib esylate in Idiopathic Pulmonary Fibrosis: NCT07194382 Clinical Landscape Report 2026
9 min read
Nintedanib esylate in Idiopathic Pulmonary Fibrosis: NCT07194382 Clinical Landscape Report 2026
18 September 2026
NCT07194382 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Perflutren lipid microsphere in Neuroinflammation: NCT07193953 Clinical Landscape Report 2026
9 min read
Perflutren lipid microsphere in Neuroinflammation: NCT07193953 Clinical Landscape Report 2026
18 September 2026
NCT07193953 clinical landscape for Neuroinflammation: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Temozolomide in Metastatic Malignant Neoplasm to the Leptomeninges: NCT07193654 Clinical Landscape Report 2026
9 min read
Temozolomide in Metastatic Malignant Neoplasm to the Leptomeninges: NCT07193654 Clinical Landscape Report 2026
18 September 2026
NCT07193654 clinical landscape for Metastatic Malignant Neoplasm to the Leptomeninges: endpoints, sponsor, phase, geography, readouts, asset context and deve…
Read →
EPC-003 in Recurrent Glioblastoma: NCT07193628 Clinical Landscape Report 2026
9 min read
EPC-003 in Recurrent Glioblastoma: NCT07193628 Clinical Landscape Report 2026
18 September 2026
NCT07193628 clinical landscape for Recurrent Glioblastoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Gallium Maltolate in Glioblastoma Multiforme: PACTR202509858954027 Clinical Landscape Report 2026
9 min read
Gallium Maltolate in Glioblastoma Multiforme: PACTR202509858954027 Clinical Landscape Report 2026
18 September 2026
PACTR202509858954027 clinical landscape for Glioblastoma Multiforme: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
Read →
Nerandomilast in Idiopathic Pulmonary Fibrosis: NCT07201922 Clinical Landscape Report 2026
9 min read
Nerandomilast in Idiopathic Pulmonary Fibrosis: NCT07201922 Clinical Landscape Report 2026
18 September 2026
NCT07201922 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
CS-060380 in Metabolic Dysfunction Associated Steatohepatitis: NCT07198386 Clinical Landscape Report 2026
9 min read
CS-060380 in Metabolic Dysfunction Associated Steatohepatitis: NCT07198386 Clinical Landscape Report 2026
18 September 2026
NCT07198386 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…
Read →
MR001 in Triple Negative Breast Cancer: NCT07208149 Clinical Landscape Report 2026
9 min read
MR001 in Triple Negative Breast Cancer: NCT07208149 Clinical Landscape Report 2026
18 September 2026
NCT07208149 clinical landscape for Triple Negative Breast Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Acamprosate Calcium in Amyotrophic Lateral Sclerosis: NCT07204977 Clinical Landscape Report 2026
9 min read
Acamprosate Calcium in Amyotrophic Lateral Sclerosis: NCT07204977 Clinical Landscape Report 2026
18 September 2026
NCT07204977 clinical landscape for Amyotrophic Lateral Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
LY-4337713 in Pancreatic Intraductal Neoplasms: NCT07213791 Clinical Landscape Report 2026
9 min read
LY-4337713 in Pancreatic Intraductal Neoplasms: NCT07213791 Clinical Landscape Report 2026
18 September 2026
NCT07213791 clinical landscape for Pancreatic Intraductal Neoplasms: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
Read →